Heme-regulated inhibitor: an overlooked eIF2α kinase in cancer investigations. | AVESİS

Kütahya Health Sciences University Research Information System

Heme-regulated inhibitor: an overlooked eIF2α kinase in cancer investigations.

Medical oncology (Northwood, London, England), vol.39, no.5, pp.73, 2022 (Journal Indexed in SCI Expanded)

Publication Type: Article / Article
Volume: 39 Issue: 5
Publication Date: 2022
Doi Number: 10.1007/s12032-022-01668-1
Title of Journal : Medical oncology (Northwood, London, England)
Page Numbers: pp.73